Join
Live feed
·
INSIDERFilingvia Quantisnow
Corbus Pharmaceuticals Holdings Inc. logo

Chief Executive Officer Cohen Yuval sold $62,465 worth of shares (7,134 units at $8.76), decreasing direct ownership by 5% to 138,187 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CRBP· Corbus Pharmaceuticals Holdings Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CRBP (Corbus Pharmaceuticals Holdings Inc.) and more on Quantisnow.